Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aiqin Zhike Granules
- Development stage
- Phase 2
- Lead developer
- Xinjiang Uygur Autonomous Region Institute of Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Aiqin Zhike Granules (艾芩止咳颗粒) is an innovative Traditional Chinese Medicine (TCM) candidate developed by Beijing Jingshi Weikang Pharmaceutical Technology Co., Ltd. It is classified as a Class 1.1 new drug in China and is specifically indicated for the treatment of acute tracheobronchitis, particularly for patients presenting with the 'wind-heat transforming into toxin' syndrome. The formulation is designed to clear heat, ventilate the lungs, resolve phlegm, and suppress cough. Pharmacologically, it is intended to exert anti-inflammatory, expectorant, and antitussive effects. The drug has progressed into Phase 3 clinical trials in China to evaluate its efficacy and safety in reducing cough severity and phlegm production compared to placebo.
- Other names
- Aiqin Zhike Keli艾芩止咳颗粒
Beyond the preview
Go deeper on Aiqin Zhike Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aiqin Zhike Granules.